Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

Autor: Romina Pagotto, Jorge Luis Pórfido, Hellen Daghero, Marcelo Hill, B. Varela, Ana Paula Arévalo, M. Duhalde Vega, Martina Crispo, Mercedes Segovia, Mariela Bollati-Fogolín, Kanji Yamasaki, José Manuel Verdes
Rok vydání: 2020
Předmět:
0301 basic medicine
Neutrophils
viruses
Diseases
medicine.disease_cause
Kidney
Gastroenterology
Monocytes
Ivermectin
Signs and symptoms
Coronavirus
Sars-Cov-2
Mice
Inbred BALB C

Multidisciplinary
biology
purl.org/becyt/ford/3.1 [https]
Viral Load
medicine.anatomical_structure
Liver
Medicine
purl.org/becyt/ford/3 [https]
Tumor necrosis factor alpha
Female
Coronavirus Infections
Viral load
medicine.drug
medicine.medical_specialty
Science
030106 microbiology
Antiviral Agents
Article
ivermectin
03 medical and health sciences
Mouse hepatitis virus
In vivo
Internal medicine
medicine
Animals
Transaminases
Murine hepatitis virus
business.industry
Tumor Necrosis Factor-alpha
Body Weight
COVID-19
Kidney metabolism
Proteins
biology.organism_classification
Disease Models
Animal

030104 developmental biology
business
Zdroj: Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
ISSN: 2045-2322
Popis: SARS-CoV2 is a single strand RNA virus member of the type 2 coronavirus family, responsible for causing COVID-19 disease in humans. The objective of this study was to test the ivermectin drug in a murine model of coronavirus infection using a type 2 family RNA coronavirus similar to SARS-CoV2, the mouse hepatitis virus (MHV). BALB/cJ female mice were infected with 6,000 PFU of MHV-A59 (Group Infected; n=20) and immediately treated with one single dose of 500 μg/kg of ivermectin (Group Infected + IVM; n=20), or were not infected and treated with PBS (Control group; n=16). Five days after infection/treatment, mice were euthanized to obtain different tissues to check general health status and infection levels. Overall results demonstrated that viral infection induces the typical MHV disease in infected animals, with livers showing severe hepatocellular necrosis surrounded by a severe lymphoplasmacytic inflammatory infiltration associated with a high hepatic viral load (52,158 AU), while ivermectin administration showed a better health status with lower viral load (23,192 AU; p
Databáze: OpenAIRE